<?xml version="1.0" encoding="UTF-8"?>
<p>On the basis of the latest preliminary reports (retrospective analyses with a reduced number of patients), COVID-19 infection was adjoined with an increased susceptibility of patients to develop thrombotic events characterized by hemostatic disturbances (most common mild thrombocytopenia and augmented level of D-dimer) and even disseminated intravascular coagulation (DIC). It is still unknown if the hemostatic disorders are a cause of SARS-CoV-2 infection or a repercussion of the cytokine storm that triggers the beginning of inflammatory response syndrome (SIRS). Another hypothesis is a possible link between the hemostatic changes and liver dysfunction [
 <xref rid="B41-jcm-09-02084" ref-type="bibr">41</xref>].
</p>
